Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863 [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetics study of topical GSK1278863 for wound healing completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wound Healing

Drugs mentioned

• GSK1278863

Snippet

Sponsor: GlaxoSmithKline | Conditions: Wound Healing | Phase 1 | Status: COMPLETED | Results posted: 2019-08-19